Categories: News

Connected Care’s Golden State Medicare Health Plan Taps AdhereHealth’s Technology to Help Improve Member Medication Adherence

NEWPORT BEACH, Calif., May 1, 2019 /PRNewswire/ — Golden State Medicare Health Plan, an HMO that specializes in the care of seniors, is deploying technology that uses advanced analytics to resolve medication adherence issues that affect patient outcomes and Medicare Advantage Star Ratings. The technology is provided by AdhereHealth™, a healthcare technology solutions leader that focuses on medication adherence and currently supports nearly 10 million consumers across the nation.

“We take a physician-led and member-centric approach – using innovative technologies is central to this mission,” said Dr. Sanjay Patil, CEO of Golden State Medicare Health Plan. “AdhereHealth’s technology helps us directly engage with our members to ensure medication adherence and improved health, an effort we can measure through higher Star Ratings.”

AdhereHealth’s technology platform, Adhere™, uses advanced analytics to identify members who need support in their medication adherence. Members experiencing medication adherence issues often are challenged by social determinants, such as poor health literacy and access to care. AdhereHealth’s nation-wide network of licensed clinicians use available health plan data and clinical workflow tools to engage directly with the consumer and their doctors to improve adherence.

“Our data-driven approach creates a positive experience for the consumer and promotes medication adherence that meaningfully improves healthcare outcomes,” said Jason Z. Rose, AdhereHealth CEO. “This also aligns perfectly with Golden State’s goal to use advanced technology to build a foundation for driving future growth and innovation across California.”

About AdhereHealth™
AdhereHealth™ is a healthcare technology solutions leader supporting health plans, self-insured employers and other risk-bearing entities for medication adherence insights and improved healthcare outcomes. The company’s Adhere™ platform touches nearly 10 million consumers through advanced technologies, at-risk engagement services and home-delivered pharmacy. The integrated set of solutions address an estimated $300 billion of unnecessary annual medical costs attributed to medication adherence issues. The company is headquartered in the Nashville suburb of Brentwood, Tennessee. For more information, please visit www.adherehealth.com.

About Golden State Medicare Health Plan
Golden State Medicare Health Plan (HMO) is a physician-led, technology-enabled Medicare Advantage Prescription Drug (MAPD) plan in California that serves its members with C.A.R.E. – compassion, accountability, respect and excellence. The plan, recently acquired by Connected Care Health Services, Inc., focuses on providing members a frictionless healthcare experience, removing barriers to health, and prioritizing access to high-cost, life-saving, life-sustaining medications that can transform health outcomes. Learn more at www.gsmhp.com.  

Contact:
Media@cchealth.com  

 

View original content:http://www.prnewswire.com/news-releases/connected-cares-golden-state-medicare-health-plan-taps-adherehealths-technology-to-help-improve-member-medication-adherence-300841875.html

SOURCE Connected Care Health Services, Inc.

Staff

Recent Posts

Fortitude Wellbeing Enhances Mental Health Services with Comprehensive ADHD Assessments

Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…

3 minutes ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

1 hour ago

Mexico’s EHR Revolution: Driving Digital Health Innovation and Market Growth, Insights From Black Book Research

Key Trends, Vendor Performance, and Opportunities Transforming Mexico's Healthcare IT Landscape MIAMI, FLORIDA / ACCESSWIRE…

1 hour ago

Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees

Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or…

4 hours ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…

4 hours ago

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused…

4 hours ago